Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Reexamination Certificate
2011-05-24
2011-05-24
Jiang, Shaojia Anna (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
C514S634000
Reexamination Certificate
active
07947741
ABSTRACT:
This invention provides for efflux pump inhibitors to be co-administered with antimicrobial agents for the treatment of infections caused by drug resistant pathogens, novel efflux pump inhibitors, combined dosage forms of efflux pump inhibitors with an antimicrobial, and novel medical methods.
REFERENCES:
patent: 4324794 (1982-04-01), Tidwell et al.
patent: 4397863 (1983-08-01), Tidwell et al.
patent: 4619942 (1986-10-01), Tidwell et al.
patent: 4823784 (1989-04-01), Bordoni et al.
patent: 4853416 (1989-08-01), Anaebonam et al.
patent: 4895719 (1990-01-01), Radhakrishnan et al.
patent: 4933347 (1990-06-01), Tidwell et al.
patent: 4963589 (1990-10-01), Tidwell et al.
patent: 5049389 (1991-09-01), Radhakrishnan
patent: 5084480 (1992-01-01), Pai et al.
patent: 5089527 (1992-02-01), Lord
patent: 5202320 (1993-04-01), Tidwell et al.
patent: 5204113 (1993-04-01), Hartley et al.
patent: 5206236 (1993-04-01), Tidwell et al.
patent: 5262157 (1993-11-01), Bernard et al.
patent: 5334374 (1994-08-01), Hartley et al.
patent: 5355872 (1994-10-01), Riggs et al.
patent: 5364615 (1994-11-01), Debs et al.
patent: 5366726 (1994-11-01), Debs et al.
patent: 5428051 (1995-06-01), Tidwell et al.
patent: 5474759 (1995-12-01), Fassberg et al.
patent: 5485827 (1996-01-01), Zapol et al.
patent: 5521189 (1996-05-01), Boykin et al.
patent: 5534496 (1996-07-01), Lee et al.
patent: 5556637 (1996-09-01), Hager et al.
patent: 5597573 (1997-01-01), Kamireddy et al.
patent: 5602172 (1997-02-01), Boykin et al.
patent: 5606058 (1997-02-01), Boykin et al.
patent: 5622955 (1997-04-01), Boykin et al.
patent: 5627184 (1997-05-01), Boykin et al.
patent: 5668166 (1997-09-01), Tidwell et al.
patent: 5668167 (1997-09-01), Tidwell et al.
patent: 5674911 (1997-10-01), Emanuele et al.
patent: 5686456 (1997-11-01), Boykin et al.
patent: 5723495 (1998-03-01), Hall et al.
patent: 5725871 (1998-03-01), Illum
patent: 5741517 (1998-04-01), Hager et al.
patent: 5770585 (1998-06-01), Kaufman et al.
patent: 5843980 (1998-12-01), Hall et al.
patent: 5869091 (1999-02-01), Carter et al.
patent: 5873359 (1999-02-01), Zapol et al.
patent: 5989832 (1999-11-01), Trias et al.
patent: 6008247 (1999-12-01), Boykin et al.
patent: 6025398 (2000-02-01), Hall et al.
patent: 6076522 (2000-06-01), Dwivedi et al.
patent: 6098619 (2000-08-01), Britto et al.
patent: 6114310 (2000-09-01), Chamberland et al.
patent: 6123924 (2000-09-01), Mistry et al.
patent: 6126919 (2000-10-01), Stefely et al.
patent: 6127554 (2000-10-01), Boykin et al.
patent: 6172104 (2001-01-01), Tidwell et al.
patent: 6180604 (2001-01-01), Fraser et al.
patent: 6204279 (2001-03-01), Leger et al.
patent: 6214883 (2001-04-01), Hall et al.
patent: 6245746 (2001-06-01), Chamberland et al.
patent: 6309623 (2001-10-01), Weers et al.
patent: 6326395 (2001-12-01), Tidwell et al.
patent: 6346391 (2002-02-01), Oethinger et al.
patent: 6362229 (2002-03-01), Markham et al.
patent: 6399629 (2002-06-01), Chamberland et al.
patent: 6416742 (2002-07-01), Stefely et al.
patent: 6423737 (2002-07-01), Hall et al.
patent: 6436980 (2002-08-01), Leger et al.
patent: 6486200 (2002-11-01), Boykin et al.
patent: 6503881 (2003-01-01), Krieger et al.
patent: 6503940 (2003-01-01), Boykin et al.
patent: 6538106 (2003-03-01), Fraser et al.
patent: 6553987 (2003-04-01), Davies
patent: 6613787 (2003-09-01), Wilson et al.
patent: 6635668 (2003-10-01), Tidwell et al.
patent: 6641800 (2003-11-01), Mistry et al.
patent: 6649652 (2003-11-01), Boykin et al.
patent: 6677133 (2004-01-01), Oethinger et al.
patent: 6720001 (2004-04-01), Chen et al.
patent: 7026136 (2006-04-01), Oethinger et al.
patent: 7037495 (2006-05-01), Burnie et al.
patent: 7056917 (2006-06-01), Nakayama et al.
patent: 0345926 (1991-08-01), None
patent: 0309519 (1992-07-01), None
patent: 0383680 (1992-12-01), None
patent: WO 96/40117 (1996-12-01), None
patent: WO 99/37667 (1999-07-01), None
patent: WO 02/09758 (2002-02-01), None
Rybak, et. al., Antimicrobial Agents and Chemotherapy, Apr. 2000, 1062-1066.
Webster's Collegiate Dictionary, 1993, p. 1096.
Dave R., et. al. Amino Acids, 24, 2003, 245-261.
Goodman & Gilman's: The Pharmacological Basis of Therapeutics, 10th Edition, McGraw-Hill Medical Publishing Division, 2001, pp. 54-56.
Yeh et. al. Pharmaceutical Research, vol. 13(4), 1996, 628-632.
Mitchell et.al. (Antimicrobial Agents and Chemotherapy, 1993, 475-477.
Definition of prophylaxis, WordNet, http://wordnet.princeton.edu, accessed online Feb. 12, 2009.
Definition of prevent, WordNet, http://wordnet.princeton.edu, accessed online Nov. 14, 2007.
Decker et al. Review of Infectious Diseases, 1991, 13(6), p. 1250-1251.
Wien et al. Brit. J. Pharmacol., 1948, 3, p. 211-218.
Rodnick et al. West. J. Med. 1991, 154, p. 405-409.
Tumbarello et al. Journal of Acquired Immune Deficiency Syndroms and Human Retrovirology, 1998, 18(1), p. 39-45, accessed online on Dec. 2, 2009.
Join-Lambert et al. Antimicrobial Agents and Chemotherapy, 2001, 45(2), p. 571-576.
Fastier et al. Journal of Pharmacology and Experimental Therapeutics, 1947, 89(3), p. 256-270.
Southan et al. European Journal of Pharmacology Molecular Pharmacology Section, 1995, 291, p. 311-318.
International Search Report and Written Opinion from International Application No. PCT/US2005/008873, mailed Jun. 26, 2007.
Poeta, et al., “In vitro antifungal activities of a series of dication-substituted carbazoles, furans, and benzimidazoles,”Antimicrobial Agents and Chemotherapy, 42(10), 2503-2510, 1998.
Anne, et al., “Antifungal and antibacterial activities of diarylamidine derivatives,”Antimicrobial Agents and Chemotherapy, 18(2), 231-9, 1980.
Bichowsky-Slomnitzki L, “Inhibitory Action of Diamidines and Stimulative Effect of Polyamines on Enzymatic Activites ofEscherichia coliandMicrococcus aureus,”Arch. Biochem., Jul. 1950, 27(2):294-303.
Bichowsky-Slomnitzki L, “The Effect of Aromatic Diamidines on Bacterial Growth,”J. Bact. 1948, 55:27-31.
Chauhan, et al., “Synthesis of 2,7-diamidinoxanthone, thioxanthone and related compounds as potential leishmanicides,”Indian J. of Chem., Section B: Organic Chemistry Including Medicinal Chemistry, 26B(3), 248-50, 1987.
Donkor IO et al., “In vitro antimicrobial activity of aromatic diamidines and diimidazolines related to pentamidine,”Eur. J. Med. Chem. 34 (1999) 639-643.
Donkor, et al., “Trypanocidal Activity of Conformationally Restricted Pentamidine Congeners,”J. Med. Chem., (2003) 46, 1041-1048.
Helweg-Larsen et al., “Pneumocystic camii Pneumonia,”Current Treatment Options in Infectious Diseases, (2002) 4:363-375.
Hicks, MR, “The Effect of Isoniàzid, Carbutamide, Propamidine and Pentamidine on the Transaminases and Growth ofEscherichia coli, Strain 15, Mutant M2,”Biochimica Et Biophysica Acta, 1961, 46:143-151.
Hsieh P-C et al., “Bacteria lacking a multidrug pump: A sensitive tool for drug discovery,”Proc. Natl. Acad. Sci., Jun. 1998, 95:6602-6606.
Kohn Hi, “The Effect of Propamidine on Bacterial Growth,”Science, 98(2540):224, 1943.
Levy, “Active Efflux Mechanisms for Antimicrobial Resistance,”Antimicrobial Agents and Chemotherapy, 36(4), 695-703, 1992.
Lewis JD et al., “Cephalosporin-pentamidine isethionate incompatibilities,”Am. J. Health-Syst. Pharm., Jun. 15, 1996, 53:1461-1462.
Libman, “Antistaphylococcal Activity of Pentamidine,”Antimicrobial Agents and Chemotherapy, Sep. 1990, 1795-1796.
Mitchell BA et al., “QacA Multidrug Efflux Pump fromStaphylococcus aureus: Comparative Analysis of Resistance to Diamidines, Biguanidines, and Guanylhydrozones,”Antimicrobial Agents and Chemotherapy, Feb. 1998:475-477.
Neyfakh, “The Mutlidrug Efflux Transporter ofBacillus subtilisIs a Structural and Functional Homolog of theStaphylococcusNorA Protein,”Antimicrobial Agents and Chemotherapy, 36(2), 484-485, 1992.
Neyfakh, et al., “Fluoroquinolone Resistance Protein NorA ofStaphylococcus aureusIs a Multidrug Efflux Transporter,”A
Bostian Keith
Glinka Tomasz
Lomovskaya Olga
Surber Mark
Jiang Shaojia Anna
Knobbe Martens Olson & Bear LLP
Lau Jonathan S
Mpex Pharmaceuticals, Inc.
LandOfFree
Use and administration of bacterial efflux pump inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use and administration of bacterial efflux pump inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use and administration of bacterial efflux pump inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2621543